Canadian Cancer Trials Group Bulletins


Kim Chi Awarded $500,000 from 3CTN

Dr. Kim Chi Dr. Kim Chi, Co-Chair of Canadian Cancer Trials Group's Genitourinary Site Committee and medical oncologist at the British Columbia Cancer Agency in Vancouver, has been awarded $500,000 from the Canadian Cancer Clinical Trials Network (3CTN) for the support of an exciting new IND Program suite of trials in castrate resistant prostate cancer, "Precision Oncology Platform for Prostate Cancer: A Phase 2 Umbrella Trial for Patients with Metastatic Castration Resistant Prostate Cancer."

This grant, which includes co-applicants from Canadian Cancer Trials Group and cancer centres across Canada, will be used to support a Master Screening Protocol and at least 4 planned phase II trials testing 7 or more different new drugs in CRPC.

You can read more about Dr. Chi and this exciting new project by using this link ...

Congratulations, Dr. Chi!!